Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Initiated Multicenter Study to Evaluate the Feasibility, Safety and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis - The Neo2 BAV Registry

NCT06212050 is registered in ClinicalTrials.gov with National University of Ireland, Galway, Ireland as lead sponsor.

NCT NCT06212050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Initiated Multicenter Study to Evaluate the Feasibility, Safety and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis - The Neo2 BAV Registry
Lead sponsor
National University of Ireland, Galway, Ireland
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2023
Completion date
June 30, 2024
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, bicuspid aortic valve, transcatheter aortic valve implantation, transcatheter aortic valve replacement